Literature DB >> 19077682

Nephrin and endothelial injury.

Peter V Hauser1, Federica Collino, Benedetta Bussolati, Giovanni Camussi.   

Abstract

PURPOSE OF REVIEW: Nephrin, the main structural protein of the slit diaphragm, is expressed on the surface of glomerular podocytes and is critical in maintaining permselectivity and preventing proteinuria. This review focuses on the fate of nephrin in the context of endothelial injury and gives an update on the recent progress in understanding the pathomechanisms that lead to proteinuria. RECENT
FINDINGS: The following conditions of endothelial injury were found to induce loss of nephrin.(1) Preeclampsia, in which the associated proteinuria is induced by the soluble variant of vascular endothelial growth factor, which stimulates production of endothelin 1 (ET1) in endothelial cells. ET1 in turn triggers nephrin shedding from podocytes.(2) Hypertension, in which increased levels of angiotensin II induce podocyte apoptosis and reduce nephrin expression, leading to proteinuria in rats.(3) Diabetes and high fat diet, which lead to a significant increase in inflammatory molecules and cytokines, including MCP-1, which induces changes in podocyte cytoskeleton and nephrin loss.
SUMMARY: Recent results showed that damage to endothelial cells may alter endothelial-podocyte interaction and induces nephrin loss, a main cause of proteinuria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19077682     DOI: 10.1097/MNH.0b013e32831a4713

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  15 in total

1.  Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.

Authors:  Xuezhu Li; Peter Y Chuang; Vivette D D'Agati; Yan Dai; Rabi Yacoub; Jia Fu; Jin Xu; Oltjon Taku; Prem K Premsrirut; Lawrence B Holzman; John Cijiang He
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

2.  Captopril attenuates hypertension and renal injury induced by the vascular endothelial growth factor inhibitor sorafenib.

Authors:  Tasuku Nagasawa; Md Abdul Hye Khan; John D Imig
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-05       Impact factor: 2.557

3.  A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension.

Authors:  Kumiko Fukuda; Akira Shimizu; Tomohiro Kaneko; Yukinari Masuda; Fumihiko Yasuda; Megumi Fukui; Seiichiro Higo; Akio Hirama; Akiko Mii; Shuichi Tsuruoka; Ryuji Ohashi; Yasuhiko Iino; Yuh Fukuda; Yasuo Katayama
Journal:  CEN Case Rep       Date:  2012-12-07

Review 4.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

5.  Early biomarkers of nephrotoxicity associated with the use of anti-VEGF drugs.

Authors:  Natalia Chebotareva; Katerina Grechukhina; Valerie Mcdonnell; Lyudmila Zhukova; Tatyana Krasnova
Journal:  Biomed Rep       Date:  2022-04-07

6.  Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.

Authors:  Hong Liu; Wei Sun; Liu-Bao Gu; Yue Tu; Bing-Yin Yu; Hao Hu
Journal:  Chin J Integr Med       Date:  2015-10-10       Impact factor: 1.978

7.  Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease.

Authors:  Bruce A Julian; Hitoshi Suzuki; Yusuke Suzuki; Yasuhiko Tomino; Goce Spasovski; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2009-08-26       Impact factor: 3.494

8.  Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.

Authors:  Timo P Hiltunen; Kati M Donner; Antti-Pekka Sarin; Janna Saarela; Samuli Ripatti; Arlene B Chapman; John G Gums; Yan Gong; Rhonda M Cooper-DeHoff; Francesca Frau; Valeria Glorioso; Roberta Zaninello; Erika Salvi; Nicola Glorioso; Eric Boerwinkle; Stephen T Turner; Julie A Johnson; Kimmo K Kontula
Journal:  J Am Heart Assoc       Date:  2015-01-26       Impact factor: 5.501

9.  Alteration of podocyte phenotype in the urine of women with preeclampsia.

Authors:  Tianyue Zhai; Itsuko Furuta; Rina Akaishi; Satoshi Ishikawa; Mamoru Morikawa; Takahiro Yamada; Takahiro Koyama; Hisanori Minakami
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

10.  Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy.

Authors:  Ruixia Ma; Liqiu Liu; Xuemei Liu; Yan Wang; Wei Jiang; Luo Xu
Journal:  Exp Ther Med       Date:  2013-07-17       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.